多学科协作治疗直肠癌伴同时性肝转移患者一例

病例讨论

鞠海星¹, 朱玉萍¹, 朱利明¹, 刘鲁迎¹, 杜义安¹, 张凌男¹, 吴伟¹, 丁国军¹, 朱远¹, 应杰儿¹, 李德川¹^,^†(

)

全文 ( ) 下载PDF ( ) 导出引用

图1 直肠癌患者初始治疗前的盆腔MRI检查图像

图2 直肠癌患者初始治疗前肝转移灶CT检查图像

图3 拟行治疗过程示意图

图4 直肠癌患者全身化疗后肝转移灶CT检查图像

图5 直肠癌患者同步放化疗盆腔MRI检查图像

[1]	Nordlinger B，Sorbye H，Glimelius B，et al.Perioperative chemotherapy withFOLFOX4 and surgery versus surgery alone for resectable liver metastases fromcolorectal cancer(EORTC Intergroup trial 40983)：a randomised controlled trial.Lancet，2008,371(9617):1007-1016.
[2]	Adam R，Delvart V，Pascal G，et al.Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy.Ann Surg，2004,240(4):644-657.
[3]	Kopetz S，Chang GJ，Overman MJ，et al.Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy.J Clin Oncol，2009,27(22):3677-3683.
[4]	Van Cutsem E，Kohne CH，Lang I，et al.Cetuximab Plus Irinotecan，Fluorouracil，and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer：Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status.J Clin Oncol，2011,29(15):2011-2019.
[5]	Bokemeyer C，Van Cutsem E，Rougier P，et al.Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer：pooled analysis of the CRYSTAL and OPUS randomised clinical trials.Eur J Cancer，2012,48(10):1466-1475.

No related articles found!

阅读次数

全文

摘要